These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17692649)

  • 1. Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction.
    Adani GL; Lorenzin D; Currò G; Sainz-Barriga M; Comuzzi C; Bresadola V; Avellini C; Baccarani U
    Transplant Proc; 2007; 39(6):1904-6. PubMed ID: 17692649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific cholestatic syndrome in liver transplantation: successful symptomatic treatment by plasma exchange.
    Bruzzone P; Alfani D; Berloco P; Iappelli M; Rossi M; Casciaro G; Caricato M; Caramiello MS; Fagiolo M; Russo GE
    Transplant Proc; 1993 Apr; 25(2):1753-4. PubMed ID: 8470153
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing for orthotopic liver transplantation in children with biliary atresia: a single-center experience.
    Toyoki Y; Hakamada K; Narumi S; Nara M; Sugai M; Munakata H; Sasaki M
    Transplant Proc; 2008 Oct; 40(8):2494-6. PubMed ID: 18929777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
    Scheingraber S; Richter S; Igna D; Girndt M; Flesch S; Kleinschmidt S; Schilling MK
    Clin Transplant; 2007; 21(6):689-95. PubMed ID: 17988260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hyperbilirubinemia in acute inflammation of appendix: a prospective study of 45 cases.
    Khan S
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):281-9. PubMed ID: 18603920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS).
    Montero JL; Pozo JC; Barrera P; Fraga E; Costán G; Domínguez JL; Muntané J; Rodriguez-Ariza A; Pleguezuelo M; Rufián S; López-Cillero P; de la Mata M
    Transplant Proc; 2006 Oct; 38(8):2511-3. PubMed ID: 17097984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestasis induced by parabolan successfully treated with the molecular adsorbent recirculating system.
    Anand JS; Chodorowski Z; Hajduk A; Waldman W
    ASAIO J; 2006; 52(1):117-8. PubMed ID: 16436902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early risk factors of acute lung injury following orthotopic liver transplantation].
    Li SR; Shen N; Hei ZQ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3049-52. PubMed ID: 19192404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation.
    Annicchiarico BE; Avolio AW; Siciliano M; Passalacqua S; Caracciolo G; Gasbarrini A; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):1929-31. PubMed ID: 18675092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants.
    Yamamoto R; Nagasawa Y; Marubashi S; Furumatsu Y; Iwatani H; Iio K; Matsui I; Dono K; Imai E; Monden M; Isaka Y
    Blood Purif; 2009; 28(1):40-6. PubMed ID: 19325238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renal failure on liver transplantation survival.
    Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of protein-bound and unbound unconjugated bilirubin by perfusion of plasma through an anion-exchange resin in a case of Crigler-Najjar syndrome type I.
    Ihara H; Shino Y; Hashizume N; Shimizu N; Aoki T; Yoshida M
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):528-33. PubMed ID: 14503990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early increase in gamma glutamyltranspeptidase and low aspartate aminotransferase peak values are associated with superior outcomes after orthotopic liver transplantation.
    Eisenbach C; Encke J; Merle U; Gotthardt D; Weiss KH; Schneider L; Latanowicz S; Spiegel M; Engelmann G; Stremmel W; Büchler MW; Schmidt J; Weigand MA; Sauer P
    Transplant Proc; 2009 Jun; 41(5):1727-30. PubMed ID: 19545716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal?
    Dezza MC; Berrevoet F; Sainz-Barriga M; Rossetto A; Colenbie L; Haentjens I; Van Vlierberghe H; Colle I; Van Huysse J; Praet M; Rogiers X; de Hemptinne B; Troisi R
    Transplant Proc; 2007 Oct; 39(8):2675-7. PubMed ID: 17954205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.